Our patent application “ISOQUINOLINE DERIVATIVES FOR USE AS ANTIVIRAL AND ANTITUMOUR AGENTS” (EP 4 322 949 B1) has been granted on March 19th, 2025. We are glad that this project moved is along now with RDP Pharma (https://rdp-pharma.com/) – we are are wishing success with progressing this interesting small molecule compounds further!